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Hypertrophy, hyperplasia and altered mucus secretion from the respiratory submucosal glands (SMG) are
characteristics of airway diseases such as cystic ﬁbrosis, asthma and chronic bronchitis. More commonly,
hyper-secretion of the nasal SMGs contributes to allergic rhinitis and upper airway infection. Considering
the role of these glands in disease states, there is a signiﬁcant dearth in understanding the molecular
signals that regulate SMG development and patterning. Due to the imperative role of FGF signalling
during the development of other branched structures, we investigated the role of Fgf10 during initiation
and branching morphogenesis of murine nasal SMGs. Fgf10 is expressed in the mesenchyme around
developing SMGs while expression of its receptor Fgfr2 is seen within glandular epithelial cells. In the
Fgf10 null embryo, Steno's gland and the maxillary sinus gland were completely absent while other
neighbouring nasal glands showed normal duct elongation but defective branching. Interestingly, the
medial nasal glands were present in Fgf10 homozygotes but missing in Fgfr2b mutants, with expression
of Fgf7 speciﬁcally expressed around these developing glands, indicating that Fgf7 might compensate for
loss of Fgf10 in this group of glands. Intriguingly the lateral nasal glands were only mildly affected by loss
of FGF signalling, while these glands were missing in Eda mutant mice, where the Steno's and maxillary
sinus gland developed as normal. This analysis reveals that regulation of nasal gland development is
complex with different subsets of glands being regulated by different signalling pathways. This analysis
helps shed light on the nasal gland defects observed in patients with hypohidrotic ectodermal dysplasia
(HED) (defect EDA pathway) and LADD syndrome (defect FGFR2b pathway).
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Impaired mucus clearance and pulmonary obstruction are
common symptoms of a number of life-threatening respiratory
diseases. Mucus hyper-secretion by the submucosal glands (SMG)
is an important etiological factor in asthma, chronic bronchitis and
cystic ﬁbrosis with SMG hyperplasia and mucous metaplasia
common to all (Reid, 1960; Oppenheimer and Esterly 1975; Aikawa
et al., 1992). Hyper-secretion and abnormal mucociliary clearance
leads to a build-up of mucus with a thick viscosity which can
obstruct airways and increase bacterial lung infection, leading to
premature death in severe cases (Oppenheimer and Esterly, 1975;
Hoegger et al., 2014; Robinson and Bye, 2002). More commonly,
altered mucus secretion of the nasal glands, particularly the sinusr Inc. This is an open access article
er).glands, gives rise to chronic rhinosinusitis and infection of the
upper airway tract (Peña et al., 2007; Wu et al., 2011). Considering
this signiﬁcant involvement of SMGs in pulmonary diseases, re-
search is lacking in the mechanisms modulating gland develop-
ment and homeostasis. To understand the progression of airway
disease, it is critical to elucidate the signalling factors and path-
ways required during SMG morphogenesis, and investigate if these
mechanisms are defective in disease states.
The SMGs are found in the submucosal connective tissue be-
neath the respiratory epithelium (RE) of the conductive airways
(Fig. 1). The anterior nasal SMGs provide the ﬁrst line of defence
within the airway. The medial and lateral glands are found within
the medial and lateral nasal walls respectively, while the sinus
glands drain their secretions directly into the sinus cavity
(Grüneberg, 1971; May and Tucker, 2015) (Fig. 1). In humans, SMGs
are further found within the submucosa between the cartilaginous
rings of the distal airways, stretching throughout the trachea and
bronchi (Borthwick et al., 1999; Sturgess and Imrie, 1982). In mice,under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Fig. 1. Schematic summary of the morphology and location of the embryonic murine nasal SMGS. (A) Representation of an anterior view of a transverse section of the nasal
SMGs surrounding the nasal cavity (white). The SMG ducts of the Steno's gland, Lateral Nasal Glands (LNGs) and Medial Nasal Glands (MNGs) open into the cavity at different
locations close to the nasal vestibule, while the maxillary sinus gland (MSG) opens into the maxillary sinus cavity (MSC). Coloured box selections of the distal glands (A) are
represented as sagittal sections (B–D). (B) Location of the MSG (red), Steno's gland (yellow) and LNG2 and 3 (green) below the MSC. (C) The LNG5 and an area of the Steno's
duct below the respiratory epithelium. (D) MNGs 1–4 in the mesenchyme of the nasal septum. LNGs 6–13 develop adjacent to LNG2, 3 and 5, and undergo gland branching at
different locations beneath the nasal cavity along the A/P body axis (not shown).
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density adjacent to the cricoid cartilage (CC) and develop no fur-
ther than the sixth cartilaginous tracheal ring (Borthwick et al.,
1999; Rawlins and Hogan, 2005).
The SMGs develop through a process of branching morpho-
genesis. This process, common to other mammalian epithelial or-
gans such as the mammary gland, salivary gland and lung, involves
the formation of a single tube from an epithelial sheath that un-
dergoes continual elongation and clefting to create a complex
network of branched tubes and terminal buds. Cellular differ-
entiation occurs within these structures to form ductal units
within the branches, while end buds differentiate into functional
units that transport liquid or gas. In SMGs, these distal functional
units are composed of serous and mucous cells that produce air-
way mucus rich in mucins and bactericidal enzymes (Meyrick
et al., 1969; Meyrick and Reid, 1970).
Members of the ﬁbroblast growth factor (FGFs) family of
polypeptide proteins have been shown to be involved in branching
morphogenesis of other organs such as the lung, salivary and la-
crimal glands. The FGF family consists of 22 ligands (FGF1–FGF22)
and four cell membrane-bound tyrosine kinase FGF receptors
(FGFR1–FGFR4) (Ornitz and Itoh, 2001). The essential requirement
for FGF10 and its receptor FGFR2b during lung morphogenesis is
emphasised by the shared defects of both Fgf10 homozygous
(/) and Fgfr2b / mice, who die at birth due to agenesis of
the lungs (Sekine et al., 1999; Min et al., 1998; De Moerlooze et al.,
2000). FGF10 and FGFR2b are also critical for salivary gland duct
elongation and branching (Jaskoll et al., 2005; Steinberg et al.,
2005). The submandibular salivary gland fails to develop past the
initial bud stage at embryonic day E12.5 in both Fgf10 / and
Fgfr2b / mice, and salivary glands are hypoplastic and secrete a
reduced volume of saliva in Fgf10 heterozygous (þ/) adults (May
et al., 2015). Mutations in FGF10 or its receptor FGFR2b, lead to
Lacrimo Auriculo Dento Digital (LADD) syndrome (OMIM 149730)in humans. This anomaly is characterized by hypoplasia, atresia or
aplasia of the salivary glands and the lacrimal glands of the eyes,
and obstruction of the nasolacrimal duct (Shiang and Holmes,
1977; Inan et al., 2006). A milder form of this disease, known as
Aplasia of Lacrimal and Salivary Glands (ALSG) (OMIM 180920),
gives rise to the same symptoms as LADD, most often including
xerothalmia (dryness of the eye) and xerostomia (dry mouth)
(Wiedemann, 1997; Milunsky et al., 1990).
The Ectodysplasin A (EDA) pathway is also required for mor-
phogenesis of many glandular structures (Mikkola, 2009). A
naturally occurring mutation in the EDA gene arises in the Tabby
mouse, leading to defective hair, tooth and salivary gland devel-
opment (Srivastava et al., 1997). Investigation of the nasal SMGs in
the Tabby mouse revealed absence of some of the nasal glands,
while others, such as Steno's gland, the largest of the nasal glands,
also known as the lateral nasal gland 1 (LNG1) (Fig. 1), developed
normally in the Tabby mouse (Grüneberg 1971). mRNA expression
of Edar, the receptor for EDA, was found in the tracheal respiratory
epithelium during postnatal SMG development (Rawlins and Ho-
gan, 2005). The absence of tracheal SMGs were observed in both
the adult Tabby mouse and postnatally in the Edaradd knockout
mouse, which lacks an EDAR signalling adapter molecule, high-
lighting the requirement of the EDA signalling pathway in suc-
cessful tracheal SMG morphogenesis (Rawlins and Hogan, 2005).
Human patients with hypohidrotic ectodermal dysplasia (HED)
have developmental defects in teeth, hair and salivary glands
caused by mutations in EDA, EDAR or EDARADD (Mikkola, 2009).
Respiratory difﬁculties and nasal gland defects have also been
reported in HED patients with nasal dryness of the nasal mucosa,
nasal crusting and abnormal nasal discharge all being symptoms of
the disease (Al-Jassim and Swift, 1996; Dietz et al., 2013).
In this study, we have investigated the requirement for FGF10/
FGFR2b and EDA signalling during the crucial stages of SMG de-
velopment among the different nasal gland populations. We
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dominantly dependent on FGF10/FGFR2b signalling from initial
stages of gland budding and elongation, while the medial and
lateral glands require this pathway for later gland branching
stages. It is suggested that the medial glands are reliant on FGF7/
FGFR2b signalling from early development while the lateral glands
are more dependent on EDA-mediated signalling. Elucidating
these heterogeneous signalling mechanisms will further our un-
derstanding in the complex organization and maintenance of
these glands, in hopes to combat disease occurrence and
progression.2. Material and methods
2.1. Experimental animals
Fgf10-deﬁcient mice were ﬁrst generated by Min et al. (1998)
(Mouse Genome Informatics ID 1099809). Fgfr2b / specimens
have been previously described (De Moerlooze et al., 2000)
(Mouse Genome Informatics ID 2153811). EdaTa/Y males and EdaTa/
Ta females were used in the analysis of the glands. All procedures
and culling methods were performed under a project licence ap-
proved by the United Kingdom's Home Ofﬁce and in accordance
with the Animal (Scientiﬁc Procedures) Act of 1986, United
Kingdom.
2.2. Animal collection
For embryo collection, adult mice were mated in the late eve-
ning and a midnight mating was assumed. Midday of the day at
which a vaginal plug was discovered was recorded as embryonic
day (E) 0.5. For postnatal pup collection, the day female mice lit-
tered down was recorded as P0. Adult males and females were
culled by exposure to rising levels of CO2 gas. Primers used to
detect wildtype Fgf10 locus were 5′-GAGGAAATGCTGCGCA-
CAATGTATACTCGG-3′ (Fgf203 forward primer) and 5′-GGA-
TACTGACACATTGTGCCTCAGCCTTTC-3′ (Fgf204 reverse primer)
while the mutant Fgf10 locus was detected by primers 5′-
GCTTGGGTGGAGAGGCTATTC-3′ (Fgf233 forward primer) and 5′-
CAAGGTGAGATGACAGGAGATC-3′ (Fgf234 reverse primer) of the
neo-cassette insert (Sekine et al., 1999). Fgfr2b and Eda mutants
were genotyped as previously described (Charles et al., 2009; De
Moerlooze et al., 2000).
2.3. Histological Staining and RNA in situ hybridisation
Upon collection, embryonic heads were ﬁxed in 4% paraf-
ormaldehyde in PBS (PFA) overnight at 4 °C. For tissue collected for
in situ hybridisation procedures, all solutions used were diethyl-
pyrocarbonate (DEPC) treated. Tissue was dehydrated in increasing
methanol concentrations and left overnight at 4 °C in Isopropanol
(Sigma Aldrich). Samples were cleared in 1,2,3,4 Tetra-
hydronapthalene at RT, and embedded in parafﬁn wax. Alternative
serial 9 mm sagittal sections were collected along the left/right axis
through the entire embryonic head.
Parafﬁn embedded sections were dewaxed using Histoclear and
rehydrated through an ethanol series. Craniofacial sections were
stained using a Trichrome stain of 1% Alcian Blue, Ehrlich's Hae-
matoxylin and 0.5% Sirius Red in saturated Picric Acid.
For in situ hybridisation of embryonic nasal tissue with digox-
igenin or S35-labelled riboprobes, sections were deparafﬁnised
and rehydrated in decreasing ethanol concentrations in DEPC
treated PBS. In situ hybridisation technique was carried out using a
modiﬁed Wilkinson protocol (Wilkinson, 1995). Fgf7 (Mason et al.,
1994), Fgf10 (Bellusci et al., 1997), Fgfr2 (Peters et al., 1992) and Eda(Tucker et al., 2000) cDNA plasmid vectors and gene inserts used
for riboprobe generation have been previously described.3. Results
3.1. Fgf10 and Fgfr2 are expressed during nasal gland development
To understand the role of the FGF pathway in nasal gland de-
velopment the expression of Fgf10 and Fgfr2 was investigated
during embryonic stages of gland initiation and branching mor-
phogenesis. At E14.5, prior to the branching of the distal Steno's
gland (Fig. 2A), Fgf10 expression was observed in the mesenchyme
surrounding the extending Steno’s duct (Fig. 2B). Fgfr2 expression
was found within the distal epithelial cells of the elongated Steno's
duct at E14.5 (Fig. 2C). During gland branching at E16.5 (Fig. 2D),
Fgf10 expression was apparent throughout the mesenchyme sur-
rounding the end buds of the Steno's gland (Fig. 2E), while Fgfr2
mRNA was evident within the epithelial cells of the gland buds
(Fig. 2F).
Fgf10 was expressed throughout the mesenchyme adjacent to
the maxillary sinus gland (MSG) primordium at E14.5 (Fig. 2G and
H), with Fgfr2 expression observed within the maxillary sinus
epithelium from which the MSG buds (Fig. 2I). During MSG
branching at E16.5 (Fig. 2J), Fgf10 expression was maintained
throughout the mesenchyme adjacent to the branching MSG end
buds (Fig. 2K). At this stage, Fgfr2 expression was lost within the
maxillary sinus epithelium however it was apparent in the distal
tips of the branching MSG end buds (Fig. 2L).
At E14.5 the duct of LNG2 had begun its elongation through the
middle conchal mesenchyme (Fig. S1A) and the bud of LNG3 had
emerged from the epithelium of the middle conchal lip (Fig. S1B)
(May and Tucker, 2015). By E16.5, LNG2 and LNG3 were seen
branching, close to the maxillary sinus cavity (Fig. S1C). At E14.5,
Fgf10was expressed in the conchal mesenchyme surrounding both
the extending LNG2 (Fig. S1D) and the budding LNG3 (Fig. S1E). At
E16.5, Fgf10 was expressed throughout the mesenchyme sur-
rounding the developing LNG end buds (Fig. S1F). Fgfr2 was ex-
pressed in the ductal epithelial cells of the elongating LNG2 (Fig.
S1G) and within the cells of the LNG3 bud (Fig. S1H) at E14.5. As
LNG2 and LNG3 were branching at E16.5, Fgfr2 was expressed
within the end bud epithelial cells of LNG2 and LNG3 (Fig. S1I). At
E16.5, when the LNG4 duct was elongating beneath the nasal
septum, Fgf10 was also expressed in the mesenchyme surrounding
the extending duct with Fgfr2 within the ductal cells (not shown).
At E14.5, the duct of medial nasal gland (MNG)1 was seen to
extend into the mesenchyme of the nasal septum (Fig. S2A) and by
E16.5, the MNGs had branched adjacent to the vomeronasal organ
(VNO) (Fig. S2B). Fgf10 was expressed throughout the mesench-
yme of the nasal septum at E14.5 when the MNG ducts were
elongating (Fig. S2C). At the branching stages of the MNGs at
E16.5, Fgf10 expression surrounded the extending glandular
branches (Fig. S2D). Fgfr2 expression was noted in the epithelial
cells of the extending MNG1 duct at E14.5 (Fig. S1E) and Fgfr2 was
expressed within the gland buds at E16.5 (Fig. S1F).
3.2. Fgf10 is critical for Steno's and MSG development
To deﬁne the role of Fgf10 in anterior nasal gland development,
we analysed the gland phenotype in wildtype (WT), Fgf10þ / and
Fgf10/ mice. At E12.5 the Steno's gland duct arises from the RE
and invaginates into the mesenchyme of the middle concha. At
this stage an epithelial pit was observed in WT mice (Fig. 3A). By
E17.5, the lumenized Steno's duct was observed through a frontal
section of the nasal region (Fig. 3B), and the majority of the
elongated anterior nasal glands had branched, as evident in a
Fig. 2. Fgf10 and Fgfr2 are expressed during Steno's gland and MSG development. Trichrome stained sagittal sections of the distal Steno's gland (A) and at stage E14.5 of
development. (B) At E14.5, Fgf10 expression is found throughout the mesenchyme beneath the maxillary sinus epithelium in the location of where the Steno's gland will
branch, while Fgfr2 is expressed in the distal epithelial cells of the Steno's duct (C). At E16.5 the Steno's gland is undergoing continual branching (D). Fgf10 is expressed in the
mesenchyme surrounding the distal gland buds (E) and Fgfr2 is evident in the distal epithelial cells of the Steno's gland end buds (F). (G) Trichrome stained sagittal section of
the MSG primordium at E14.5. Fgf10 is expressed throughout the mesenchyme surrounding the MSG primordium at E14.5 (H) and Fgfr2 mRNA is detected in the maxillary
sinus epithelium, of which the MSG buds (I). By E16.5 when the MSG is branching (J), Fgf10 is expressed in the mesenchyme surrounding the branching MSG end buds (K). By
E16.5, Fgfr2 expression is lost from the maxillary sinus epithelium but found within the distal end buds of the MSG (L). Yellow line¼Steno's gland; blue line¼basement
membrane of the maxillary sinus epithelium, red line¼MSG; orange line¼maxillary sinus lumen. Scale bar¼100 mm.
A.J. May et al. / Developmental Biology 419 (2016) 348–356 351more caudal sagittal section (Fig. 3C). At E17.5, the MNGs had
extensively branched throughout the nasal septum mesenchyme
(Fig. 3D).
In Fgf10þ / mice, the epithelial invagination of the Steno's
duct had formed at E12.5, similarly to WT mice (Fig. 3E). At E17.5,
the Steno's gland developed in Fgf10þ / animals and its duct(Fig. 3F) elongated to the correct location underneath the max-
illary sinus (Fig. 3 – yellow), however, the extent of branching was
reduced (Fig. 3G). Similarly, branching of the MSG, LNGs, and
MNGs was also noticeably reduced in Fgf10þ / mice (Fig. 3G and
H) compared to that observed in WTs.
In Fgf10 / embryos, no Steno's duct pit was apparent at
Fig. 3. The Steno's gland and MSG fail to develop in Fgf10 / mice. (A) Indentation of the Steno's gland duct is observed in WT animals at E12.5. At E17.5, the Steno's duct
(B) and gland (C–D) are well established in WT animals, as well as the MSG (C – red), LNGs (C – green) and MNGs (D). (E) Similar development is seen in Fgf10þ/ littermates
as the Steno's duct dips into the underlying mesenchyme at E12.5. At E17.5, the Steno's duct is found in Fgf10þ/ animals (F), and the distal gland has developed however a
reduction in branching is evident (G – yellow). Reduced branching of the LNGs (G – green), MSG (G – red) and MNGs (H) is also observed in Fgf10þ / embryos. (I) No Steno's
ductal pit is found in the Fgf10 / mouse. An epithelial placode swelling occurs however, and development appears to arrest at this stage. At E17.5, the Steno's duct (J) and
gland (K), and the MSG (K) are completely absent in the Fgf10 / animal. The LNG (K) and MNG (L) ducts extend to their correct location in the Fgf10 / however
branching of the distal glands is severely defective. Steno's gland¼yellow; MSG¼red; LNG2 and 3¼green; MNG¼blue; asterisks represent absent gland. Column1 scale
bar¼100 mm, Column2 scale bar¼50 mm, Column 3 and 4 scale bar¼100 mm.
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critical for the initial invagination of the duct of the Steno's gland.
By E17.5, complete absence of the Steno's duct (Fig. 3J) and gland
(Fig. 3K – yellow asterisks) was observed in Fgf10 / mice. Ad-
ditionally, the MSG was absent with complete loss of Fgf10 (Fig. 3K
– red asterisks). The LNGs were observed in Fgf10 / mice at
E17.5 (Fig. 3K). Their ducts budded and elongated to the correct
locations when compared to WT specimens, however branching of
the distal glands was signiﬁcantly reduced (Fig. 3K). Furthermore,
the MNGs were severely defective with truncated ducts and a
considerable reduction in branching, following complete loss of
Fgf10 (Fig. 3L).
3.3. Fgfr2b is critical for Steno's gland, MSG, LNG4 and MNG
development
Given that only a subset of glands failed to develop in Fgf10
mutants we decided to assess whether other FGF ligands, working
through the same receptor as FGF10, were critical for development
of the lateral and medial nasal glands. We therefore investigated
the gland phenotype in Fgfr2b knockout mice at E18.5, when the
majority of glands have extended and started to branch. Similarly
to Fgf10 homozygous mutants, the Steno's gland and MSG were
completely absent in Fgfr2b/ mice (Fig. 4A–D). The lateral nasal
glands (LNG2,3,5) were also present as in the Fgf10/ , but again
with reduced branching (Fig. 4C–F and data not shown). Un-
expectedly, however, LNG4, which normally forms underneath thenasal cartilage capsule, was completely absent in Fgfr2b deﬁcient
animals at E18.5 (Fig. 4G–H). Additionally, unlike the Fgf10 /
phenotype, the MNGs were also completely absent with loss of
Fgfr2b (Fig. 4I–J). This indicates that other FGFs that bind to FGFR2b
are required for MNG and LNG4 duct elongation.
3.4. Fgf7 is expressed during medial nasal gland development
Considering the absence of the MNGs in the Fgfr2b / mouse,
yet the presence of MNG ducts and primary branches in the Fgf10
homozygous embryo, we assessed the expression of Fgf7 during
normal gland development. FGF7 is closely related to FGF10 and
also binds to FGFR2b with high afﬁnity (Zhang et al., 2006). Fgf7
was not found in the mesenchyme surrounding the Steno's gland
during any of the duct elongation stages (Fig. 5A) or gland
branching (Fig. 5B). Fgf7 expression was observed surrounding the
nasolacrimal duct (NLD) and this was used as a positive control of
gene expression (Fig. 5B inset image). No Fgf7 expression was as-
sociated with LNG or MSG development (Fig. 5C–F). Fgf7 expres-
sion was observed throughout the septal mesenchyme at E14.5,
close to where the medial nasal glands were forming (Fig. 5G). As
the MNG ducts were elongating Fgf7 expression was maintained in
the anterior septal mesenchyme close to the elongating ducts
(Fig. 5H). These results suggest that MNG duct elongation may be
reliant on FGF7 or another FGF ligand with high afﬁnity to FGFR2
such as FGF1 and FGF22. Multiple FGFs may therefore compensate
for the development of these glands.
Fig. 4. Fgfr2b expression is critical for Steno's gland, MSG, LNG 4 and MNG de-
velopment. (A–B) The MSG develops from the maxillary sinus epithelium in WTs
however fails to develop in Fgfr2b deﬁcient mice. (C) The distal LNG2 and Steno's
gland develop in WT animals. (D) The Steno's gland is completely absent in
Fgfr2b / mice. LNG2 is found in Fgfr2b / animals however branching of the
gland is reduced (D). (E) A branched LNG3 has developed by E18.5 in WT animals.
(F) The LNG3 duct extends to the same location in Fgfr2b/ mice however
branching of the distal gland is reduced. (G–H) Both LNG4 glands are found below
the nasal cartilage capsule in WT animals, however are completely absent with the
loss of Fgfr2b. (I–J) The MNGs are completely absent in Fgfr2b / mice compared
to their WT littermates, indicated by absence of the MNG ducts. Scale bar¼100 mm.
Fig. 5. Fgf7 is expressed in the septal mesenchyme during nasal gland develop-
ment. (A) At E14.5 Fgf7 expression is not associated with the elongating Steno's
duct. (B) When the Steno's gland is branching at E15.5 no Fgf7 is observed near the
branching gland. Fgf7 expression is still maintained in the mesenchyme sur-
rounding the NLD (B – inset image). (C) Fgf7 expression is not found associated with
the elongate LNG2 and 3 ducts or (D) the budding LNG5 at E15.5. (E) Fgf7 ex-
pression is not associated with the epithelium where the MSG will bud at E14.5 or
(F) surrounding the branching MSG at E15.5. (G) At E14.5, a section through the
nasal septum shows Fgf7 expression throughout the mesenchyme. (H) At E15.5,
Fgf7 expression is seen in the anterior mesenchyme of the nasal septum close to the
elongating MNG ducts. A–F scale bar¼100 mm, G-H scale bar¼200 mm.
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Histological analysis has previously indicated that some of the
nasal glands are defective in Tabby mutant mice (Grüneberg,
1971). We therefore decided to study the nasal glands of EdaTa/Y
male and EdaTa/Ta female (Tabby) mice (referred to for simplicity as
EdaTa) in more detail to compare to the Fgf mutants. Edar, en-
coding the receptor for EDA, was found to be expressed in the
nasal gland epithelium during duct extension and branching
(Fig. 6A–C). Despite expressing components of the EDA pathway,
the Steno's gland and MSG developed normally in EdaTa mice
(Fig. 6D–I). Investigation of the LNG glands showed that only LNG3
and LNG8 develop in EdaTa mutants, while no other ducts of the
other LNGs were found either in the lateral nasal wall (Fig. 6J–K) or
the middle conchal lip (Fig. 6L–M). Similarly, to the Fgfr2b knock-
out mouse, LNG 4, beneath the nasal cartilage capsule, was absent
in the EdaTa mutant (Fig. 6N–O). At a more rostral location,
branching of LNG3 was observed to be severely defective in the
EdaTa mouse compared to WT littermates (Fig. 6P–Q). Finally, the
MNGs were completely absent in EdaTa mice (Fig. 6R–S).4. Discussion
4.1. Fgf10 is essential for nasal gland branching morphogenesis
The anterior nasal glands provide a wonderful model for
studying branching morphogenesis due to their prolonged duct
elongation stage and subsequent gland branching. This allows the
investigation of different pathways and signalling molecules in-
volved in these distinct stages of organogenesis. In this study, it
was elucidated that Fgf10 is essential for gland branching of all of
the anterior nasal glands. Although branching of the glands occurs
in an array of temporal locations, expression of Fgf10 mRNA was
seen throughout the mesenchyme surrounding the gland end buds
of all glands during their branching stages. This expression pattern
of Fgf10 is similar to that observed during mammalian lung de-
velopment where Fgf10 mRNA is localised to the mesenchyme
surrounding newly developing lung buds (Bellusci et al., 1997). In
the lung, Fgf10 has been shown to trigger cell proliferation and act
as a chemoattractant (Bellusci et al., 1997; Park et al., 1998), and
the expression pattern described in our study suggests a similar
role in nasal SMG development. Examination of Fgf10 mutant
mouse also emphasised that with one copy of Fgf10 present in the
heterozygotes, branching of the nasal glands occurs however is
reduced. In the complete absence of Fgf10 in the homozygotes,
gland branching is seriously defective with only the presence of
severely truncated end buds at the distal ductal tips. The
Fig. 6. EDA signalling is required for LNG and MNG development. (A–C) In situ hybridisation of frontal sections through the nasal chamber during development reveals Eda
expression in the LNGs and MNGs (A), the Steno's gland (B) and MSGs (C). At E17.5, the Steno's duct (D, F), gland (E, G) and MSGs (H, I) have developed in EdaTA mice similar
to WT littermates. Ducts of LNG11–13 are absent in the lateral nasal wall of EdaTA mice (J–K), and ducts of LNG2, 5 and 6 are absent in the medial conchal lip (L–M). LNG3 and
LNG8 ducts develop normally in the EdaTA mouse (J–M). Beneath the cartilage of the nasal capsule, LNG4 is absent with the loss of EDA signalling (N–O). Branching of the
distal LNG3 gland is reduced in (P–Q) and all of the MNGs are absent (R–S) in the EdaTA mouse. Scale bars¼100 mm.
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gland and salivary gland aplasia present in the mouse model and
human LADD syndrome (Entesarian et al., 2007; May et al., 2015).
4.2. FGF10 plays a heterogeneous role in early anterior nasal gland
development
The complete absence of the Steno's gland in the Fgf10/
mouse indicates this growth factor's pivotal role in the develop-
ment of this structure. This gland differs from the other nasal
glands as it buds approximately 24 h earlier and the duct bud in-
vaginates into the mesenchyme as an epithelial indentation, as
opposed to a solid swelling of cells (May and Tucker, 2015). In this
way the development is more akin to the development of the lung,
where the lumen is an integral part of the invaginating epithelium,
rather than the lacrimal or salivary glands, where the lumen forms
later due to cavitation of a solid cord. The maxillary sinus gland is
unusual in that it branches immediately from the maxillary sinus
epithelium without formation of an extending duct, so here the
loss of the gland is linked to the essential role of Fgf10 in branching
morphogenesis. In contrast to these glands, the lateral nasal glands
(LNG), despite expressing Fgf10 from early stages, had normal duct
elongation in the Fgf10/ mice, while the medial nasal glands
were also less severely affected. Due to the complexity of biolo-
gical regulatory networks, removal of one or some of its elements
does not necessarily contribute to its overall collapse (Jeong et al.,
2000; Albert et al., 2000). Therefore, other signalling molecules
appear to compensate for the loss of FGF10.
4.3. Other signalling molecules are required for lateral and medial
nasal gland development
The loss of the medial nasal glands in the Fgfr2b/ mice
indicate that another FGF, working through this receptor, is able to
compensate for loss of FGF10. A likely candidate is FGF7. The
amino acid core of FGF7 shows over 60% sequence identity with
that of Fgf10, making it the most structurally similar growth factor
to Fgf10 (Yamasaki et al., 1996). Biological functions are also con-
served between these two mesenchymally expressed Fgfs, em-
phasised by both the ligands having high afﬁnity to FGFR2b.
During mouse lung development, Fgf7 is not expressed in the lung
mesenchyme during early endoderm branching at E11.5 however
Fgf7 transcripts are detected when the lung is undergoing ex-
tensive branching between E13.5 and E14.5 (Bellusci et al., 1997).
Early studies using culture of mesenchyme-free endoderm with
FGF7 protein showed that it stimulates endoderm stalk extension
by inducing cell proliferation (Cardoso et al., 1997). While Fgf7
expression was not as evident as that of Fgf10 in the periocular
mesenchyme during normal in vivo lacrimal gland development,
application of an FGF7 bead to lacrimal gland explant cultures
induced ectopic gland bud formation, similarly to FGF10 protein
application, however not at as high a rate (Makarenkova et al.,
2000). In comparison, culture of submandibular salivary glands
with FGF7 only gave rise to moderate stalk extension and instead
induced epithelial bud enlargement (Koyama et al., 2008). The
localisation of Fgf7 mRNA in the nasal septum mesenchyme from
E14.5 to E15.5 when the MNG ducts are budding, elongating and
beginning to branch suggest that Fgf7 function may be utilised by
these developing glands in the absence of Fgf10. Fgf7 mutants do
not display gland defects, suggesting that Fgf10 is able to com-
pensate for loss of Fgf7 in those glands where both are expressed
(Guo et al., 1996).
LNG2, LNG3 and LNG5 all bud and elongate as ducts to the
presumptive branching location independent of FGFR2b signalling.
Due to the abundant amount of lateral nasal glands found in both
rodents and humans, understanding the development of theseglands is important in elucidating causes of nasal conditions such
as rhinitis and sinusitis. Interestingly the lateral nasal glands, with
the exception of LNG3 and 8, failed to form in the Eda mutants,
while LNG3 had severely reduced branching. These lateral glands
therefore rely more heavily on the EDA pathway for their devel-
opment, with the pathway being important for both duct devel-
opment and branching. The medial nasal glands were also missing,
similar to the Fgfr2b/ . These glands therefore require both EDA
and FGF signalling for their correct development.
From this study we want to emphasise that nasal SMGS not
only adopt contrasting temporal locations and methods of devel-
opment, they each employ different signalling factors and in-
tracellular cues for their tightly controlled duct elongation and
glandular branching. This is important as we can assume defects in
different subsets of nasal glands in patients with LADD syndrome
and HED. LADD syndrome is caused by mutations in one copy of
Fgfr2b or Fgf10, therefore the heterozygous mice are a good model
for this disorder. Importantly branching morphogenesis of all nasal
glands was reduced in the Fgf10þ/ mice, suggesting that a si-
milar reduction in branching would be found in the nasal glands of
LADD patients. XL-HED is caused by complete loss of EDA function,
and our results suggest that the lateral and medial nasal glands
would be particularly affected in these patients. Such a dramatic
loss of these key glands, which cannot be compensated by FGF
signalling, would explain the reported defects in this region
(Al-Jassim and Swift, 1996; Dietz et al., 2013), although the ante-
rior nasal gland (analogous to the Steno's gland) would be ex-
pected to form normally in HED patients.Acknowledgements
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